Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

We're HUGE

FSD Pharma (CSE Symbol: HUGE) is transforming a large facility in Cobourg, Ontario Canada, into the largest hydroponic indoor cannabis production and processing facility in the world, with multiple business units co-supporting each other, operating under a single roof to exploit economies of scale and operational efficiencies.

Licensed Producer

Health Canada ACMPR licensed producer

Space to Grow

Existing 620,000 sq. ft. facility on 70 Acres, significant room for expansion

Debt Free

Facility is wholly owned with zero debt

Phased in Expansion

Planned stage-phased expansion to be the world’s largest indoor hydroponic facility

Capacity to Meet Growing Demand

Potential to host more than 3.8 million sq. ft. of cultivation and processing area and meet demand for the highest quality pharmaceutical grade medicinal and consumer product

Investor Confidence Second to None

All-time daily volume record of more than 78 million Class B subordinate shares traded on the CSE on first day of trading – Largest weekly volume of over 269 million Class B subordinate shares traded on the CSE

Optimal Location

Cobourg facility situated about one hour from Toronto with access to highway 401 and rail lines allowing for same day delivery of products to patients and consumers.

Optimal Growing Conditions

Indoor growing provides optimal conditions to produce superior products and the variety the market demands.

NEWS & EVENTS

March 13, 2019

FSD Pharma Announces New Leadership Appointment and Board Change

February 28, 2019

FSD Pharma Enters into Five Year Supply and Loan Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

February 19, 2019

FSD Pharma Receives Standard Processing License

February 14, 2019

FSD Pharma Provides Update on Operations, Strategy and Leadership

February 12, 2019

FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

FSD Pharma Completes Harvest and Passes Analytical Testing of Second Lot

FSD Pharma Inc. is pleased to announce that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed cannabis producer under the Cannabis Act, has completed the harvest of its second lot of cannabis and successfully passed all analytical testing….

LEARN MORE